Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients
Copenhagen, Denmark, Friday 12 June 2009: 92.8% of patients with systemic lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL), according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark. Logistic regression analysis revealed that depression was the most significant factor shown to affect QoL (p=0.015; OR=0.18; CI 95%:0.045-0.72). In the study, 92.8% (52 of 56) of the patients who were diagnosed with SLE had an element of confirmed neuropsychiatric (NP) involvement (including anxiety, depression, mild cognitive deficits and major NP involvement). Several other conditions that may occur alongside SLE were also shown to influence aspects of QoL (as measured by a selection of health assessment tools), including:
- Cutaneous (skin) conditions as Raynaud's phenomenon (identified in 37.5% of the patients)
- Serositis (identified in 8.9% of the patients)
- Hyperhomocysteinemia (a blood disorder that is a risk factor for coronary artery disease) (identified in 39.3% of the patients)
- Antiphospholipid antibodies (a disorder of coagulation) (identified in 66.1% of the patients)
Dr Paola Tomietto of the University of Trieste, Italy, who conducted the study, said: "People with SLE experience a range of both psychological and physical symptoms which can negatively impact their quality of life. This study shows that the psychological impact of SLE on quality of life includes elements of anxiety and depression. Thus, clinicians should try to identify and address the presence of mood disorders in their SLE patients in order to improve both their emotional quality of life but and, ultimately, their physical functioning."
56 consecutive SLE patients undertook the Medical Outcome Survey Short Form 36 (SF-36), to assess health-related quality of life, the Hospital Anxiety and Depression Scale and a neuropsychological battery for testing cognitive deficits. Neuropsychiatric and extra-cerebral involvement, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) damage indexes, antiphospholipid antibodies and hyperhomocysteinemia were recorded for all the patients. Data were analysed through the Spearman correlation coefficient and a logistic regression analysis.
SLICC-DI was correlated with the physical activity (PA) subscale of the SF-36 (r=-0.44; p=0.001) and with the physical component summary (PCS) (r=-0.267; p=0.047); it was related also to the number of NP events (r=0.35; p=0.007). SLEDAI did not correlate with any of the subscale of SF-36. The total summary score, the PCS and the mental component summary (MCS) scores of the SF-36 were all inversely correlated with the number of NP events (for all r=-0,5, p<0,001) and, in particular, with anxiety and depression (for TSC r=-0,56, p<0.001); any relationship was found with non-psychiatric cerebral manifestations.
SLE is a complex autoimmune disease characterised by chronic inflammation and damage to body tissues, which occurs as a result of the production of abnormal antibodies that target and cause damage to cells of the patient's body, including immune cells. SLE has the potential to affect a variety of areas of the body, including the heart, lungs, kidneys, joints, and/or nervous system. The course of the disease is unpredictable, with periods of illness (called flares) alternating with remission. Lupus can occur at any age but is most common in women, particularly of non-European descent.
Source: European League Against Rheumatism
Articles on the same topic
- Canakinumab shows promising efficacy and tolerability in children with systemic JIAMon, 15 Jun 2009, 13:37:34 UTC
- Increased levels of certain cytokines and chemokines predict onset of rheumatoid arthritisMon, 15 Jun 2009, 13:37:33 UTC
- Tracking levels of key biomarkers reflects disease activity and progression of rheumatoid arthritisMon, 15 Jun 2009, 13:37:32 UTC
- RA individuals from lower GDP countries keep working despite worse symptoms than richer countriesFri, 12 Jun 2009, 19:39:40 UTC
- Over half of people with rheumatoid arthritis have periodontitisFri, 12 Jun 2009, 19:39:36 UTC
- Better access to info and dialogue with HCPs on sexual issues for rheumatology patientsFri, 12 Jun 2009, 14:08:58 UTC
- 63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likelyFri, 12 Jun 2009, 14:08:55 UTC
- Diagnosis of arthritis 5 years earlier in childless women compared to those with childrenFri, 12 Jun 2009, 14:08:52 UTC
- 1/4 of patients on highest investigational doses of CP-690,550 achieve ACR70 at week 12Fri, 12 Jun 2009, 14:08:47 UTC
- New treatment strategy offers hope to RA patients who failed all other therapiesFri, 12 Jun 2009, 14:08:42 UTC
- Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritisFri, 12 Jun 2009, 14:08:37 UTC
- Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus modelsThu, 11 Jun 2009, 14:58:51 UTC
Other sources
- Tracking levels of key biomarkers reflects disease activity and progression of rheumatoid arthritisfrom PhysorgMon, 15 Jun 2009, 15:14:53 UTC
- Canakinumab shows promising efficacy and tolerability in children with systemic JIAfrom Science BlogMon, 15 Jun 2009, 13:35:30 UTC
- Increased levels of certain cytokines and chemokines predict onset of rheumatoid arthritisfrom Science BlogMon, 15 Jun 2009, 13:35:30 UTC
- Tracking levels of key biomarkers reflects disease activity and progression of rheumatoid arthritisfrom Science BlogMon, 15 Jun 2009, 13:35:28 UTC
- RA individuals from lower GDP countries keep working despite worse symptoms than richer countriesfrom PhysorgFri, 12 Jun 2009, 21:28:52 UTC
- Over Half Of People With Rheumatoid Arthritis Have Periodontitisfrom Science DailyFri, 12 Jun 2009, 19:35:57 UTC
- New Approach To Prevent Antibody-mediated Damage In Kidney Transplantsfrom Science DailyTue, 9 Jun 2009, 2:21:35 UTC